Fresenius Kabi AG has expanded KabiCare, its US patient support program, to include KabiConnect, a copay assistance scheme for the company’s generic oncology medicines. Kabi has described itself as having “the most comprehensive portfolio of generic injectable oncology medicines in the US.”
KabiConnect offers eligible patients financial support for more than 30 different oncology medicines, with the potential to lower out-of-pocket costs...




